Sirolimus Eluting Coronary Stent System - India CDSCO Medical Device Registration

Sirolimus Eluting Coronary Stent System is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/MD/2019/000227_dd9e936185c45bb38483da5470752fd4_0c1c336e48643b0a0ff17d1cab984a26. This device is marketed under the brand name Racer PC. The license holder is Translumina Therapeutics LLP, and it is classified as Device Class Class D. The approving authority is CDSCO -North Zone, Ghaziabad.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class D

Sirolimus Eluting Coronary Stent System

UID: MFG/MD/2019/000227_dd9e936185c45bb38483da5470752fd4_0c1c336e48643b0a0ff17d1cab984a26

Brand Name

Racer PC

License Holder

Translumina Therapeutics LLP

Device Class

Class D

Approving Authority

CDSCO -North Zone, Ghaziabad

Product Information

Sirolimus Eluting Coronary Stent System used for treatment of: •Symptomatic coronary artery disease due to discrete de novo or restenosis lesion in native coronary artery. •Symptomatic coronary artery disease due to culprit lesion in saphenous vein graft. •Treatment of Coronary lesion in patients undergoing primary or rescue PCI for acute ST segment elevation myocardial infarction (Racer PC) •Treatment of coronary lesion having athero thrombotic appearance in patients with non-ST- elevation acute coronary syndromes (Racer PC)